Coloplast lacks overview of suppliers' gas dependence

Should Russia cut off Europe from gas, Coloplast’s suppliers might suddenly face a problem – but CFO Anders Lonning-Skovgard can’t say to what extent. ALK’s main supplier would get off scot-free, says CEO Carsten Hellmann.

Even companies that don't use gas themselves could be affected by a potential supply stop from Russia, if their suppliers are dependent on the energy type

Coloplast is tracking a number of ”geopolitical challenges,” as the company’s chief financial officer, Anders Lonning-Skovgaard puts it to MedWatch.

One of these is the situation concerning what happens to the Danish medtech company’s suppliers should the conflict between Europe and Russia escalate into a full gas stop.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

FDA fast-tracks Eli Lilly's obesity candidate

Tirzepatide is already approved for type 2 diabetes, and Lilly has been vying for access to the obesity market for a while – the day the drug could be approved in both indications has now been moved up.

Jefferies spots weaknesses in GN

One potential chink in GN’s armor is that the company’s newly announced hearing aid platform, Omnia, isn’t predicted to win significant market shares.

Further reading

Related articles

Latest news

See all jobs